442 related articles for article (PubMed ID: 32092967)
41. Allosteric folding correction of F508del and rare CFTR mutants by elexacaftor-tezacaftor-ivacaftor (Trikafta) combination.
Veit G; Roldan A; Hancock MA; Da Fonte DF; Xu H; Hussein M; Frenkiel S; Matouk E; Velkov T; Lukacs GL
JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32853178
[TBL] [Abstract][Full Text] [Related]
42. Full Rescue of F508del-CFTR Processing and Function by CFTR Modulators Can Be Achieved by Removal of Two Regulatory Regions.
Uliyakina I; Botelho HM; da Paula AC; Afonso S; Lobo MJ; Felício V; Farinha CM; Amaral MD
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630527
[TBL] [Abstract][Full Text] [Related]
43. Lumacaftor and ivacaftor in the management of patients with cystic fibrosis: current evidence and future prospects.
Kuk K; Taylor-Cousar JL
Ther Adv Respir Dis; 2015 Dec; 9(6):313-26. PubMed ID: 26416827
[TBL] [Abstract][Full Text] [Related]
44. Phosphorylation of the Chaperone-Like HspB5 Rescues Trafficking and Function of F508del-CFTR.
Degrugillier F; Aissat A; Prulière-Escabasse V; Bizard L; Simonneau B; Decrouy X; Jiang C; Rotin D; Fanen P; Simon S
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32650630
[TBL] [Abstract][Full Text] [Related]
45. Precise Targeting of miRNA Sites Restores CFTR Activity in CF Bronchial Epithelial Cells.
De Santi C; Fernández Fernández E; Gaul R; Vencken S; Glasgow A; Oglesby IK; Hurley K; Hawkins F; Mitash N; Mu F; Raoof R; Henshall DC; Cutrona MB; Simpson JC; Harvey BJ; Linnane B; McNally P; Cryan SA; MacLoughlin R; Swiatecka-Urban A; Greene CM
Mol Ther; 2020 Apr; 28(4):1190-1199. PubMed ID: 32059764
[TBL] [Abstract][Full Text] [Related]
46. Lumacaftor/ivacaftor combination for cystic fibrosis patients homozygous for Phe508del-CFTR.
Zhang W; Zhang X; Zhang YH; Strokes DC; Naren AP
Drugs Today (Barc); 2016 Apr; 52(4):229-37. PubMed ID: 27252987
[TBL] [Abstract][Full Text] [Related]
47. Cystic fibrosis transmembrane conductance regulator modulators: precision medicine in cystic fibrosis.
Burgener EB; Moss RB
Curr Opin Pediatr; 2018 Jun; 30(3):372-377. PubMed ID: 29538046
[TBL] [Abstract][Full Text] [Related]
48. Extent of rescue of F508del-CFTR function by VX-809 and VX-770 in human nasal epithelial cells correlates with SNP rs7512462 in SLC26A9 gene in F508del/F508del Cystic Fibrosis patients.
Kmit A; Marson FAL; Pereira SV; Vinagre AM; Leite GS; Servidoni MF; Ribeiro JD; Ribeiro AF; Bertuzzo CS; Amaral MD
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1323-1331. PubMed ID: 30716472
[TBL] [Abstract][Full Text] [Related]
49. Modulators of CFTR. Updates on clinical development and future directions.
Bardin E; Pastor A; Semeraro M; Golec A; Hayes K; Chevalier B; Berhal F; Prestat G; Hinzpeter A; Gravier-Pelletier C; Pranke I; Sermet-Gaudelus I
Eur J Med Chem; 2021 Mar; 213():113195. PubMed ID: 33524685
[TBL] [Abstract][Full Text] [Related]
50. Pathogen acquisition in patients with cystic fibrosis receiving ivacaftor or lumacaftor/ivacaftor.
Singh SB; McLearn-Montz AJ; Milavetz F; Gates LK; Fox C; Murry LT; Sabus A; Porterfield HS; Fischer AJ
Pediatr Pulmonol; 2019 Aug; 54(8):1200-1208. PubMed ID: 31012285
[TBL] [Abstract][Full Text] [Related]
51. The cystic fibrosis airway milieu enhances rescue of F508del in a pre-clinical model.
Gentzsch M; Cholon DM; Quinney NL; Boyles SE; Martino MEB; Ribeiro CMP
Eur Respir J; 2018 Dec; 52(6):. PubMed ID: 30287473
[No Abstract] [Full Text] [Related]
52. Chronic β2AR stimulation limits CFTR activation in human airway epithelia.
Brewington JJ; Backstrom J; Feldman A; Kramer EL; Moncivaiz JD; Ostmann AJ; Zhu X; Lu LJ; Clancy JP
JCI Insight; 2018 Feb; 3(4):. PubMed ID: 29467332
[TBL] [Abstract][Full Text] [Related]
53. Changes in Airway Microbiome and Inflammation with Ivacaftor Treatment in Patients with Cystic Fibrosis and the G551D Mutation.
Harris JK; Wagner BD; Zemanick ET; Robertson CE; Stevens MJ; Heltshe SL; Rowe SM; Sagel SD
Ann Am Thorac Soc; 2020 Feb; 17(2):212-220. PubMed ID: 31604026
[No Abstract] [Full Text] [Related]
54. Differential thermostability and response to cystic fibrosis transmembrane conductance regulator potentiators of human and mouse F508del-CFTR.
Bose SJ; Bijvelds MJC; Wang Y; Liu J; Cai Z; Bot AGM; de Jonge HR; Sheppard DN
Am J Physiol Lung Cell Mol Physiol; 2019 Jul; 317(1):L71-L86. PubMed ID: 30969810
[TBL] [Abstract][Full Text] [Related]
55. Pharmacokinetics and safety of cavosonstat (N91115) in healthy and cystic fibrosis adults homozygous for F508DEL-CFTR.
Donaldson SH; Solomon GM; Zeitlin PL; Flume PA; Casey A; McCoy K; Zemanick ET; Mandagere A; Troha JM; Shoemaker SA; Chmiel JF; Taylor-Cousar JL
J Cyst Fibros; 2017 May; 16(3):371-379. PubMed ID: 28209466
[TBL] [Abstract][Full Text] [Related]
56. Cystic fibrosis papers of the year 2017.
Doull I
Paediatr Respir Rev; 2018 Jun; 27():2-5. PubMed ID: 29627168
[TBL] [Abstract][Full Text] [Related]
57. Distinctive lipid signatures of bronchial epithelial cells associated with cystic fibrosis drugs, including Trikafta.
Liessi N; Pesce E; Braccia C; Bertozzi SM; Giraudo A; Bandiera T; Pedemonte N; Armirotti A
JCI Insight; 2020 Aug; 5(16):. PubMed ID: 32673287
[TBL] [Abstract][Full Text] [Related]
58. NBD2 Is Required for the Rescue of Mutant F508del CFTR by a Thiazole-Based Molecule: A Class II Corrector for the Multi-Drug Therapy of Cystic Fibrosis.
Brandas C; Ludovico A; Parodi A; Moran O; Millo E; Cichero E; Baroni D
Biomolecules; 2021 Sep; 11(10):. PubMed ID: 34680050
[TBL] [Abstract][Full Text] [Related]
59. Extracellular phosphate enhances the function of F508del-CFTR rescued by CFTR correctors.
Saint-Criq V; Wang Y; Delpiano L; Lin J; Sheppard DN; Gray MA
J Cyst Fibros; 2021 Sep; 20(5):843-850. PubMed ID: 34020896
[TBL] [Abstract][Full Text] [Related]
60. Cystic Fibrosis Transmembrane Conductance Regulator Attaches Tumor Suppressor PTEN to the Membrane and Promotes Anti Pseudomonas aeruginosa Immunity.
Riquelme SA; Hopkins BD; Wolfe AL; DiMango E; Kitur K; Parsons R; Prince A
Immunity; 2017 Dec; 47(6):1169-1181.e7. PubMed ID: 29246444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
